Bisphosphonates
The Bisphosphonate YM529 Inhibits Osteolytic and Osteoblastic Changes and CXCR-4–Induced Invasion in Prostate Cancer Bisphosphonates and Cancer-Induced Bone Disease: Beyond Their Antiresorptive Activity
Zoledronic Acid
Anticancer Effects of Zoledronic Acid against Human Osteosarcoma Cells
Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis Zoledronic Acid Suppresses Lung Metastases and Prolongs Overall Survival of Osteosarcoma-Bearing Mice Recommendations for Zoledronic Acid Treatment of Patients with Bone Metastases Zoledronic acid induces osteosarcoma cell death by aif translocation and cell cycle arrest in S and G2/M phases